⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Rocuronium

روکورونیوم

⚠ Unverified

🦴 Musculo-Skeletal SystemNon-depolarising neuromuscular blocker

🤰 Pregnancy:Use with caution 👶 Children:Use with caution 👴 Older adults:Use with caution 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA219260 ATC M03AC09

Market / country: 🇺🇸 USA

Zemuron (US)

🧮 Dose calculator

Disease / regimen

Tracheal intubation and neuromuscular blockade · Regimen source: FDA Rocuronium · 2.2 FDA Rocuronium · 2.6

• Titrate with a peripheral nerve stimulator (TOF). Experienced clinicians only. FDA Rocuronium · 2.1
• Children: 0.45 mg/kg may suffice depending on the anaesthetic technique. FDA Rocuronium · 2.6

Formulation

Age *

Weight (kg) *

Enter age and weight.

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity (e.g. anaphylaxis) to rocuronium or other neuromuscular blockers. FDA Rocuronium · 4

Warnings

• Anaphylaxis; only with adequate anaesthesia (no paralysis without sedation); accidental administration can be fatal. FDA Rocuronium · 5 FDA Rocuronium · 2.1

Formulations

10 mg/mL (50 mg/5 mL, 100 mg/10 mL) — injection 🇺🇸 USA FDA Rocuronium · 3
10 mg/mL = 10,000 mcg/mL (for infusion rate) — injection 🇺🇸 USA FDA Rocuronium · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Rocuronium · 8.1
“Rocuronium bromide injection should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Rocuronium · 8.4
“The use of rocuronium bromide injection has been studied in pediatric patients 3 months to 14 years of age under halothane anesthesia.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Rocuronium · 8.5
“Clinical experiences and recommendations for use in geriatric patients are discussed in other sections [see Dosage and Administration (2.6) , Warnings and Precautions (5.5) , Clinical Pharmacology (12.2) , and Clinical Studies (14.2) ] .”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA219260
DailyMed (FDA label)FDA Rocuronium
MedlinePlus (NIH)❌ None
WHO ATC/DDDM03AC09
Darooyab (Iran)Rocuronium

🇮🇷 Registered in Iran Darooyab · G-2811/Rocuronium

Dosage forms with Iranian generic codes, per Darooyab.

17084 · ROCURONIUM BROMIDE 50MG/5ML AMP · آمپول روکورونیوم بروماید ۵۰ میلی‌گرم / ۵ میلی‌لیتر
52073 · ROCURONIUM BROMIDE INJECTION, SOLUTION PARENTERAL 10 mg/1mL 10 mL · محلول تزریقی روکورونیوم بروماید ۱۰ میلی‌گرم / ۱ میلی‌لیتر ۱۰ میلی‌لیتر

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Rocuronium · 3 FDA Rocuronium · 2.2 FDA Rocuronium · 2.6 FDA Rocuronium · 2.1 FDA Rocuronium · 2.3 FDA Rocuronium · 2.4 FDA Rocuronium · 2.5 FDA Rocuronium · 4 FDA Rocuronium · 5 FDA Rocuronium · SPL approval / marketing category FDA Rocuronium · 8.1 FDA Rocuronium · 8.4 FDA Rocuronium · 8.5
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-2811/Rocuronium
Clinical review⚠ Unverified

🔗 Similar drugs

For the same diseases

Succinylcholine (suxamethonium)